Skip to main content

Table 1 Monitoring parameters in cohort of study

From: Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia

Parameters Mean (SD) N (%)
Weight   501
Initial weight 66.7 (12.8)  
Last weight 66.1 (13.1)  
   Weight Change   
Increase - 177 (35.3%)
Decrease - 262 (52.3%)
No change - 62 (12.4%)
Fasting Plasma Glucose   501
Initial 22.7 (116.3)  
During 8.4 (2.4)  
Last 8.2 (2.4)  
HbA1c test   
Initial 7.9 (1.8) 123 (24.6)
During 7.9 (1.6) 215 (42.9)
Last 8.2 (1.9) 194 (38.7)
Total Cholesterol   501
Initial 63.5 (232.1)  
During 63.4 (152.0)  
Last 25.1 (139.1)  
Triglycerides   501
Initial 65.8 (243.9)  
During 27.8 (158.6)  
Last 19.7 (132.6)  
Low-density Lipoprotein   501
Initial 101.1 (295.9)  
During 45.3 (199.7)  
Last 39.1 (185.5)  
High-density Lipoprotein   501
Initial 67.1 (247.7)  
During 31.2 (170.2)  
Last 21.2 (139.7)  
Alkaline Phosphatase-ALP   501
Initial 158.3 (262.1)  
During 124.4 (197.8)  
Last 104.3 (159.4)  
Alanine Transferase - ALT   501
Initial 111.3 (276.1)  
During 70.1 (204.4)  
Last 50.0 (155.7)